ArticleCell biology and toxicology2025

Targeting B4GALT3 in BMSCs-EVs for Therapeutic Control of HCC via NF-κB pathway inhibition.

Juncheng Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.